Anthracycline- and trastuzumab-induced cardiotoxicity: a retrospective study Yasmin HamiraniIbrahim FanousPatrick Dillon Short Communication 22 June 2016 Article: 82
Medical hospitalizations in prostate cancer survivors Jerome GnanarajShobana BalakrishnanWaseem Khaliq Original Paper 20 June 2016 Article: 81
Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC) M. AbbasS. SteffensP. Ivanyi Original Paper 17 June 2016 Article: 80
Efficiency versus effectiveness: impact of molecular testing on healthcare costs and clinical outcome of patients with indeterminate thyroid nodules Emmanuel Labourier Letter to the Editor 15 June 2016 Article: 79
Use of complementary and alternative medicine by patients with cancer: a cross-sectional study at different points of cancer care J. Kleine WortmannA. BremerJ. Huebner Original Paper 14 June 2016 Article: 78
Docetaxel-related toxicity in metastatic hormone-sensitive and metastatic castration-resistant prostate cancer Michael T. SchweizerRoman GulatiHeather H. Cheng Original Paper 14 June 2016 Article: 77
Non-surgical organ preservation strategies for locally advanced laryngeal tumors: what is the Italian attitude? Results of a national survey on behalf of AIRO and AIOM D. AlterioP. FrancoB. A. Jereczek Fossa Original Paper 11 June 2016 Article: 76
Expression level and methylation status of three tumor suppressor genes, DLEC1, ITGA9 and MLH1, in non-small cell lung cancer Dorota Pastuszak-LewandoskaJacek KordiakEwa Brzeziańska-Lasota Original Paper 10 June 2016 Article: 75
Molecular evaluation of PIK3CA gene mutation in breast cancer: determination of frequency, distribution pattern and its association with clinicopathological findings in Indian patients Firoz AhmadAnuya BadweBibhu Ranjan Das Original Paper 09 June 2016 Article: 74
Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT/Cyclin D1/CDK4 pathway in vitro and in vivo Meng GaoYanyan MaZengtao Wei Original Paper 08 June 2016 Article: 73
Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients Pierfrancesco FrancoFrancesca ArcadipaneUmberto Ricardi Original Paper 08 June 2016 Article: 72
Comparison of KRAS mutation status between primary tumor and metastasis in Chinese colorectal cancer patients Zhe-Zhen LiLong BaiRui-Hua Xu Original Paper 06 June 2016 Article: 71
Neuropeptide Y1 receptor inhibits cell growth through inactivating mitogen-activated protein kinase signal pathway in human hepatocellular carcinoma Xiufang LvFengbo ZhaoWenxin Qin Original Paper 04 June 2016 Article: 70
Limited significance of curative surgery in Borrmann type IV gastric cancer Eun Young KimHan Mo YooCho Hyun Park Original Paper 01 June 2016 Article: 69
The role of IL-37 in cancer Vivi A. DingZiwen ZhuYujiang Fang Review Article 01 June 2016 Article: 68
ABO blood groups in relation to breast carcinoma incidence and associated prognostic factors in Moroccan women S. ZouineF. MarnissiN. Habti Original Paper 30 May 2016 Article: 67
Malignant gliomas induce and exploit astrocytic mesenchymal-like transition by activating canonical Wnt/β-catenin signaling Ping LuYajing WangRong Hu Original Paper 28 May 2016 Article: 66
Sequential addition of aprepitant in patients receiving carboplatin-based chemotherapy Seiichiro SuzukiMasato KarayamaTakafumi Suda Short Communication 27 May 2016 Article: 65
Letrozole-induced functional changes in carcinoma-associated fibroblasts and their influence on breast cancer cell biology Kaifu LiHua KangHaichen Sun Original Paper 27 May 2016 Article: 64
A look inside the mechanistic black box: Are red blood cells the critical effectors of RRx-001 cytotoxicity? Pedro CabralesJan ScicinskiBryan Oronsky Original Paper 26 May 2016 Article: 63
A pilot trial of FLOT neoadjuvant chemotherapy for resectable esophagogastric junction adenocarcinoma Ali Al-FakeehLorenzo FerriThierry Alcindor Short Communication 26 May 2016 Article: 62
K-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis Tao LiYuanting ZhengWeimin Cai Review Article 25 May 2016 Article: 61
Glycogen synthase kinase-3β antagonizes ROS-induced hepatocellular carcinoma cell death through suppression of the apoptosis signal-regulating kinase 1 Na ZhangLu LiuHongbin Deng Original Paper 24 May 2016 Article: 60
